www.childcancer.org.uk - Information for patients & families affected by childhood cancer
 
Clinical Trials

The Protocol

This states all the information relating to purpose, design and conduct of the trial. It defines which patients are eligible; which treatments are to be evaluated; how each patient's response is to be assessed; the end point for evaluating treatment and how the study will be coordinated.

Main features of a Protocol are:

Background and general aims; specific objectives; patient selection (inclusion and exclusion) criteria; diagnostic tests; treatment schedules; methods of patient response evaluation; trial design; arrangements for registration and, where appropriate, randomisation of patients; required size of study; monitoring of trial progress; forms and data handling; protocol deviations; plans for statistical analysis; admin.responsibilities parent/patient information sheets and consent forms.

>>>> How is the size of a clinical trial determined? >>>>

  1. Introduction
  2. What is a Clinical Trial?
  3. Clinical Trial procedure
  4. The role of the Chief Investigator
  5. The Protocol
  6. How is the size of a clinical trial determined?
  7. What is a multi-centre trial?
  8. Role of coordinating centre/Trials Unit
  9. What is randomisation?
  10. How is a patient randomised for a particular trial?
  11. What is a control in clinical trials?
  12. Forms and data management
  13. Statistics in clinical trials
  1. The role of the trial coordinator
  2. Follow up
  3. How is the trial data analysed/evaluated?
  4. What are pharmacokinetic studies?
  5. Ethical issues
  6. Conduct of Clinical Trials/Research
  7. What is a blind trial?
  8. Interpretation and publication of findings
  9. Survival Curves
  10. UKCCSG Protocols – development and approval process
  11. References
  12. Download PDF
Related information links: